Tonya McSherry

Tonya McSherry is director of New Markets at Oxford Nanopore Technologies with a focus on enabling the technology across the clinical and applied markets.  Tonya started her genomic career supporting the development of a newborn screening test for SCID followed by use of whole genome sequencing to understand complex diseases such as diabetes before supporting the advancement of many large-scale genome studies across Europe.  With a passion to see a change in standard of care with genomics, Tonya is dedicated to improving health outcomes and sustainability which will transform today’s society.